Fmoc-L-Dab(Mtt)-OH

Fmoc-L-Dab(Mtt)-OH is an Fmoc-protected, L-configured amino acid derivative in which the side-chain is a diamino group masked as an Mtt (methyltrityl) protected amine, while the α-amino functionality is protected as the fluorenylmethoxycarbonyl carbamate. The molecule therefore presents a stable, base-tolerant Fmoc group for solid-phase peptide synthesis compatibility and an acid-labile Mtt group that can be selectively removed to reveal a reactive side-chain amine after peptide assembly. The stereogenic center at the α-position is fixed in the L-configuration, enabling stereochemically defined peptide incorporation and downstream structure-function studies. The combination of aromatic protecting groups and orthogonal deprotection behavior yields a controlled reactivity profile suitable for peptide building block preparation, side-chain functionalization, and protected amino acid intermediate synthesis.

1. Peptide Synthesis

Fmoc-L-Dab(Mtt)-OH supports peptide building block preparation for solid-phase and solution-phase peptide synthesis where orthogonal protecting-group logic is required. The Fmoc carbamate enables standard N-terminal deprotection to generate a nucleophilic amine for peptide coupling, while the Mtt-protected side-chain amine remains masked during chain elongation to prevent undesired crosslinking or branching. The revealed side-chain amine after selective Mtt removal can participate in subsequent coupling, acylation, or urea/amide formation, enabling controlled incorporation of diamino-containing motifs. Downstream peptide analog construction benefits from the defined L-stereochemistry and from the ability to introduce side-chain functionality late in the synthesis sequence, aligning with common peptide chemistry workflows and applied synthetic methodology.

2. Side-Chain Functionalization

Fmoc-L-Dab(Mtt)-OH is suitable for amino acid derivatization strategies that target the side-chain diamino functionality while maintaining an Fmoc-protected handle for sequential synthesis steps. The Mtt group provides a protection state that can be removed to expose a primary amine, enabling formation of amide linkages, sulfonamides, carbamates, and other nitrogen-containing substituents through standard acylation or coupling chemistries. The orthogonal nature of Fmoc and Mtt supports stepwise installation of functional groups such as solubilizing moieties, reactive handles for conjugation, or sterically tuned substituents for molecular recognition studies. The resulting functionalized derivatives can serve as intermediates for peptidomimetics, chemical biology probes, and scaffold diversification where precise side-chain substitution patterns are required.

3. Bioconjugation Chemistry

Fmoc-L-Dab(Mtt)-OH can be applied in bioconjugation and chemical biology workflows that rely on controlled exposure of an amine for attachment to biomolecules or biomolecule-derived polymers. The protected side-chain amine allows synthesis of amine-bearing peptide constructs with minimized off-target reactions during assembly, while selective deprotection can generate a defined conjugation site for subsequent coupling to activated esters, isothiocyanates, aldehydes, or other electrophiles. The diamino-derived side chain can also support formation of stable linkages that maintain the integrity of peptide backbones during conjugate handling and analytical characterization. The stereodefined α-center and the orthogonal deprotection strategy make the compound useful for preparing conjugation-ready peptide intermediates and for generating site-controlled bioconjugates used in biochemical research and applied labeling schemes.

4. Peptidomimetics And SAR Studies

Fmoc-L-Dab(Mtt)-OH is relevant to peptidomimetic construction and structure-activity relationship studies where diamino-containing motifs influence binding modes and physicochemical properties. The Fmoc-protected backbone supports incorporation into peptide-like scaffolds, while the Mtt-protected side chain enables systematic variation of side-chain substitution after assembly to probe how steric and electronic changes affect molecular recognition. The ability to introduce defined side-chain functional groups can support SAR-driven library synthesis of constrained or functionalized analogs, including urea, amide, and sulfonamide variants derived from the exposed amine. The fixed L-configuration and controlled deprotection behavior help maintain stereochemical consistency across analog series, supporting reproducible scaffold generation in medicinal chemistry and biochemical research contexts.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-L-Dab(Mtt)-OH can be used as a manufacturing-oriented intermediate for producing protected amino acid sequences that feed into peptide-based active ingredient synthesis and related fine chemical operations. The Fmoc group provides a robust N-protection strategy compatible with common peptide coupling and deprotection cycles, while the Mtt-protected side-chain amine supports orthogonal processing to install or unveil functionality at a defined stage of the manufacturing route. The diamino side chain can be leveraged to generate downstream derivatives such as side-chain acylated intermediates, branching-capable intermediates, or conjugation-ready peptide fragments used in process chemistry for controlled intermediate formation. The compound's protected, stereodefined structure supports scalable peptide building block preparation and downstream transformation into functionalized peptide intermediates used in pharmaceutical intermediate preparation and specialty chemical production.

1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

2. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

3. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

4. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis